Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Don’t Let Static Charges or Air Drafts Disrupt Weighing Accuracy

Tuesday, November 28, 2017

External factors that can influence weighing accuracy are often overlooked even though an unreliable weighing result can have a profound effect downstream on the quality of the final result Watch the ondemand webinar Worryfree weighing Dealing with s...

Selvita Promotes Edyta Jaworska to the Management Board to Strengthen Development in Integrated Drug Discovery Services

Thursday, November 30, 2017

The Supervisory Board of Selvita SA WSESLV has appointed Mrs Edyta Jaworska to the position of a Management Board Member responsible for the development of its integrated drug discovery servicesMrs Jaworska joined Selvita in starting as a Busine...

Second Sartorius Research Xchange Forum Focuses On Regenerative Medicine and Cell Therapy

Thursday, November 30, 2017

Promoting interdisciplinary exchange between science and industry on the topics of regenerative medicine and cell therapy this is the objective Sartorius will be pursuing by hosting its second Research Xchange Forum on March and at Sartorius Colle...

Orchard Therapeutics Announces Expansion of Technical Operations in California

Thursday, November 30, 2017

Orchard Therapeutics a clinicalstage biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies today announced the opening of a second facility for technical operations in the San Fran...

TherapeuticsMD Announces Resubmission of New Drug Application for TX-004HR

Thursday, November 30, 2017

TherapeuticsMD Inc an innovative womens healthcare company announced today that it has resubmitted the New Drug Application NDA for TXHR the companys investigational applicatorfree estradiol vaginal softgel capsule for the treatment of moderatetoseve...

Agendia’s MammaPrint® Breast Cancer Risk-of-Recurrence Test Obtains Favorable Final Payment Determination from CMS for New, Unique Category 1 CPT Code

Wednesday, November 29, 2017

Agendia Inc a world leader in personalized medicine and molecular cancer diagnostics announces that its MammaPrint Gene Breast Cancer RiskofRecurrence Test has received a favorable payment determination for CY from the Centers for Medicare and Medic...

Ardelyx and Kyowa Hakko Kirin Announce License Agreement for Tenapanor for Cardiorenal Diseases in Japan

Wednesday, November 29, 2017

Ardelyx Incand Kyowa Hakko Kirin Co Ltd today announced that they have entered into a license agreement that provides Kyowa Hakko Kirin with exclusive rights to develop and commercialize Ardelyxs lead investigational product tenapanor for the treatme...

PhaseRx Receives Positive Opinion for Orphan Drug Designation for PRX-ASL from European Medicines Agency

Wednesday, November 29, 2017

PhaseRx Inc a biopharmaceutical company developing mRNA treatments for lifethreatening inherited liver diseases in children today announced that the European Medicines Agencys EMA Committee for Orphan Medicinal Products COMP has issued a positive opi...

SOTIO Broadens Its Phase II Clinical Trial Program in Ovarian Cancer

Tuesday, November 28, 2017

SOTIO a biotechnology company owned by the PPF Group today announced the enrollment of the first patient to a Phase II study testing DCVACOvCa in combination with standard of care chemotherapy for patients with ovarian cancer after first relapse Base...

Biohaven Completes Enrollment In Second Pivotal Phase 3 Clinical Trial Of Oral CGRP-Receptor Antagonist Rimegepant

Tuesday, November 28, 2017

Biohaven Pharmaceutical Holding Company Ltd announced completion of enrollment in Study BHV the Companys second pivotal Phase clinical trial examining the efficacy and safety of rimegepant in the acute treatment of migraine The trial began shortly a...